Display search results for ** instead (51 products)

Showing 1-10 of 51

This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.

USD 600.00

USD 450.00 save 25 %

12 Feb 2016  |  Global

Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016

Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories

This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.

USD 450.00

USD 337.50 save 25 %

04 Feb 2016  |  Global

Vital Signs - Spiraling US Drug Costs, Wearable Healthcare Technologies and the Zika Virus, An Analysis

Urgent Remedial Action Required as Nearly 1/4th US Prescription Drug Users Find it Difficult to Afford their Prescriptions

This issue of Vital Signs discusses why the US pays more than other countries for drugs, the inside story on wearable electronics, the spreading Zika virus, and soaring US drug costs.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

USD 450.00

USD 337.50 save 25 %

This edition of Inside R&D Alert depicts the current landscape and new trends in a series of developments associated with innovations in research and development initiatives in energy storage, water purification, micro-supercapacitors, and cardiovascular implants. Inside R&D Alert covers global innovations that are in research and development in v...

USD 250.00

USD 187.50 save 25 %

This edition of the Inside R&D TOE depicts research and development initiatives in in blood brain barrier, prosthetics, water filtration technologies, rainwater storage systems, and opthalmoscopes. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We pr...

USD 250.00

USD 187.50 save 25 %

This edition of the Inside R&D TOE depicts Innovations in air conditioners, diabetes testing, touch sensing technologies, and therapies for liver diseases. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovati...

USD 250.00

USD 187.50 save 25 %

The latest edition of Inside R&D TOE profiles innovations across a variety of technology domains. Predominantly, these technologies are in the pre-commercialization phase, or have just been approved for the market. This edition showcases a diagnostic method for the detection of concussions, a novel cancer immunotherapy vaccine, and technologies for...

USD 250.00

USD 187.50 save 25 %

Showing 1-10 of 51